edaravone

E133688

Edaravone is a neuroprotective drug used to slow functional decline in patients with amyotrophic lateral sclerosis (ALS).

All labels observed (1)

Label Occurrences
edaravone canonical 9

How this entity was disambiguated

Statements (48)

Predicate Object
instanceOf antioxidant ⓘ
free radical scavenger ⓘ
neuroprotective agent ⓘ
pharmaceutical drug ⓘ
small molecule ⓘ
approvedBy FDA ⓘ
U.S. Food and Drug Administration ⓘ
belongsToDrugClass free radical scavengers ⓘ
neuroprotective drugs ⓘ
developedFor treatment of amyotrophic lateral sclerosis ⓘ
eliminatedBy kidney ⓘ
FDAApprovalYear 2017 ⓘ
firstApprovedForALS Japan ⓘ
firstApprovedForIndication acute ischemic stroke in Japan ⓘ
hasATCCode N07XX11 ⓘ
hasBlackBoxWarning risk of hypersensitivity reactions including anaphylaxis (U.S.) ⓘ
hasBrandName Radicava ⓘ
Radicava ORS ⓘ
Radicut ⓘ
hasCASNumber 89-25-8 ⓘ
hasChemicalFormula C10H10N2O ⓘ
hasCommonAdverseEffect contusion ⓘ
eczema ⓘ
gait disturbance ⓘ
headache ⓘ
respiratory failure ⓘ
hasEliminationHalfLife approximately 4.5 to 6 hours (intravenous) ⓘ
hasIUPACName 3-methyl-1-phenyl-2-pyrazolin-5-one ⓘ
hasLegalStatus prescription-only medicine ⓘ
hasMechanismOfAction reduces oxidative stress ⓘ
scavenges free radicals ⓘ
hasMolarMass 174.20 g/mol ⓘ
hasPharmacologicalAction neuroprotection in motor neurons ⓘ
hasPregnancyCategory not well established in humans ⓘ
hasRouteOfAdministration intravenous ⓘ
oral ⓘ
hasSeriousAdverseEffect anaphylaxis ⓘ
hypersensitivity reactions ⓘ
hasTargetPopulation adult patients with ALS ⓘ
hasTherapeuticEffect slows functional decline in ALS patients ⓘ
indication treatment of ALS in adults ⓘ
isAdministeredOnSchedule cyclic dosing regimen for ALS ⓘ
isContraindicatedIn patients with history of hypersensitivity to edaravone ⓘ
patients with sulfite hypersensitivity (for some formulations) ⓘ
metabolizedBy liver ⓘ
treats ALS ⓘ
amyotrophic lateral sclerosis ⓘ
wasFirstApprovedIn Japan ⓘ

How these facts were elicited

Referenced by (9)

Full triples — surface form annotated when it differs from this entity's canonical label.

ALS → hasTreatment → edaravone ⓘ
Radicava → hasActiveIngredient → edaravone ⓘ
Radicava → hasGenericName → edaravone ⓘ
Radicava ORS → hasActiveIngredient → edaravone ⓘ
subject linked to: Radicava
Radicut → tradeNameOf → edaravone ⓘ
Radicut → hasActiveIngredient → edaravone ⓘ